Nano Dimension appointed Ofir Baharav to its Board of Directors

– ISRAEL, Ness-Ziona – Nano Dimension, a leading printing electronics company in the area of 3D printing (TASE: NNDM, OTCQX: NNDMY), announced yesterday that Ofir Baharav has joined the company’s Board of Directors.

Mr. Baharav, currently a partner in Stratus Venture Group, has served in a range of senior roles in the 3D printing sector and has extensive experience working with the venture capital community in Silicon Valley.

He gained experience in the 3D printing industry as Vice President, Product Portfolio for Stratasys. He also founded Xjet and served as the company’s CEO for six years, where he raised $60M. Previously, Mr. Baharav founded and sold a healthcare technology company, Healinx, to McKesson for $50M.

Mr. Baharav is named on more than 10 software and hardware patents and holds an MBA from Warwick Business School.

Amit Dror, CEO of Nano Dimension, commented: “Mr. Baharav is an ideal fit for the Board of Directors. His presence in the Silicon Valley area, as well as his many years of experience in digital and 3D printing, will help to strengthen the Company’s relationships with customers and expand our visibility and awareness in the U.S. market.”

About Nano Dimension

Nano Dimension, founded in 2012, focuses on development of advanced 3D printed electronics systems. Nano Dimension’s unique products combine three advanced technologies: 3D inkjet, 3D software and nanomaterials. The company’s primary products include the first 3D printer dedicated to printing multi-layer PCBs (printed circuit boards) and advanced nanotechnology-based conductive and dielectric inks.

Nano Dimension trades on OTCQX® Best Market in the U.S. and on the TASE in Israel. The Bank of New York Mellon serves as the depositary for Nano Dimension. U.S.

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.

here the original post =>